Genome-wide pathway analysis of breast cancer

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The aim of this study was to identify candidate single-nucleotide polymorphisms (SNPs) that might affect susceptibility to breast cancer and then elucidate their potential mechanisms and generate SNP-to-gene-to-pathway hypotheses. A genome-wide association study (GWAS) dataset of breast cancer that included 453,852 SNPs from 1,145 breast cancer patients and 1,142 control subjects of European descent was used in this study. The identify candidate causal SNPs and pathways (ICSNPathway) method was applied to the GWAS dataset. ICSNPathway analysis identified 16 candidate SNPs, 13 genes, and 7 pathways, which together revealed 7 hypothetical biological mechanisms. The strongest hypothetical biological mechanism was that rs3168891 and rs2899849 alter the role of MBIP in the inactivation of mitogen-activated protein kinase (MAPK) (p < 0.001; false discovery rate (FDR) = 0.038). The second strongest mechanism was that rs2229714 modulates RPS6KA1 to affect its role in growth hormone signaling (p = 0.001; FDR = 0.039). The third strongest mechanism was that rs2230394 modulates ITGB1 to regulate the PTEN pathway and hsa04360 (axon guidance pathway) (p < 0.001; FDR = 0.039, 0.041). Use of the ICSNPathway to analyze breast cancer GWAS data identified 16 candidate SNPs, 13 genes (including MBIP, RPS6KA1, and ITGB1), and 7 pathways that might contribute to the susceptibility of patients to breast cancer.

Original languageEnglish
Pages (from-to)7699-7705
Number of pages7
JournalTumor Biology
Volume35
Issue number8
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Single Nucleotide Polymorphism
Genome
Breast Neoplasms
Genome-Wide Association Study
Genes
Mitogen-Activated Protein Kinases
Growth Hormone

Keywords

  • Breast cancer
  • Genome-wide association study
  • Pathway-based analysis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Genome-wide pathway analysis of breast cancer. / Lee, Young Ho; Kim, Jae Hoon; Song, Gwan Gyu.

In: Tumor Biology, Vol. 35, No. 8, 01.01.2014, p. 7699-7705.

Research output: Contribution to journalArticle

Lee, Young Ho ; Kim, Jae Hoon ; Song, Gwan Gyu. / Genome-wide pathway analysis of breast cancer. In: Tumor Biology. 2014 ; Vol. 35, No. 8. pp. 7699-7705.
@article{840b6c758f2447c4b1945c8b17afb0c1,
title = "Genome-wide pathway analysis of breast cancer",
abstract = "The aim of this study was to identify candidate single-nucleotide polymorphisms (SNPs) that might affect susceptibility to breast cancer and then elucidate their potential mechanisms and generate SNP-to-gene-to-pathway hypotheses. A genome-wide association study (GWAS) dataset of breast cancer that included 453,852 SNPs from 1,145 breast cancer patients and 1,142 control subjects of European descent was used in this study. The identify candidate causal SNPs and pathways (ICSNPathway) method was applied to the GWAS dataset. ICSNPathway analysis identified 16 candidate SNPs, 13 genes, and 7 pathways, which together revealed 7 hypothetical biological mechanisms. The strongest hypothetical biological mechanism was that rs3168891 and rs2899849 alter the role of MBIP in the inactivation of mitogen-activated protein kinase (MAPK) (p < 0.001; false discovery rate (FDR) = 0.038). The second strongest mechanism was that rs2229714 modulates RPS6KA1 to affect its role in growth hormone signaling (p = 0.001; FDR = 0.039). The third strongest mechanism was that rs2230394 modulates ITGB1 to regulate the PTEN pathway and hsa04360 (axon guidance pathway) (p < 0.001; FDR = 0.039, 0.041). Use of the ICSNPathway to analyze breast cancer GWAS data identified 16 candidate SNPs, 13 genes (including MBIP, RPS6KA1, and ITGB1), and 7 pathways that might contribute to the susceptibility of patients to breast cancer.",
keywords = "Breast cancer, Genome-wide association study, Pathway-based analysis",
author = "Lee, {Young Ho} and Kim, {Jae Hoon} and Song, {Gwan Gyu}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s13277-014-2027-5",
language = "English",
volume = "35",
pages = "7699--7705",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "8",

}

TY - JOUR

T1 - Genome-wide pathway analysis of breast cancer

AU - Lee, Young Ho

AU - Kim, Jae Hoon

AU - Song, Gwan Gyu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The aim of this study was to identify candidate single-nucleotide polymorphisms (SNPs) that might affect susceptibility to breast cancer and then elucidate their potential mechanisms and generate SNP-to-gene-to-pathway hypotheses. A genome-wide association study (GWAS) dataset of breast cancer that included 453,852 SNPs from 1,145 breast cancer patients and 1,142 control subjects of European descent was used in this study. The identify candidate causal SNPs and pathways (ICSNPathway) method was applied to the GWAS dataset. ICSNPathway analysis identified 16 candidate SNPs, 13 genes, and 7 pathways, which together revealed 7 hypothetical biological mechanisms. The strongest hypothetical biological mechanism was that rs3168891 and rs2899849 alter the role of MBIP in the inactivation of mitogen-activated protein kinase (MAPK) (p < 0.001; false discovery rate (FDR) = 0.038). The second strongest mechanism was that rs2229714 modulates RPS6KA1 to affect its role in growth hormone signaling (p = 0.001; FDR = 0.039). The third strongest mechanism was that rs2230394 modulates ITGB1 to regulate the PTEN pathway and hsa04360 (axon guidance pathway) (p < 0.001; FDR = 0.039, 0.041). Use of the ICSNPathway to analyze breast cancer GWAS data identified 16 candidate SNPs, 13 genes (including MBIP, RPS6KA1, and ITGB1), and 7 pathways that might contribute to the susceptibility of patients to breast cancer.

AB - The aim of this study was to identify candidate single-nucleotide polymorphisms (SNPs) that might affect susceptibility to breast cancer and then elucidate their potential mechanisms and generate SNP-to-gene-to-pathway hypotheses. A genome-wide association study (GWAS) dataset of breast cancer that included 453,852 SNPs from 1,145 breast cancer patients and 1,142 control subjects of European descent was used in this study. The identify candidate causal SNPs and pathways (ICSNPathway) method was applied to the GWAS dataset. ICSNPathway analysis identified 16 candidate SNPs, 13 genes, and 7 pathways, which together revealed 7 hypothetical biological mechanisms. The strongest hypothetical biological mechanism was that rs3168891 and rs2899849 alter the role of MBIP in the inactivation of mitogen-activated protein kinase (MAPK) (p < 0.001; false discovery rate (FDR) = 0.038). The second strongest mechanism was that rs2229714 modulates RPS6KA1 to affect its role in growth hormone signaling (p = 0.001; FDR = 0.039). The third strongest mechanism was that rs2230394 modulates ITGB1 to regulate the PTEN pathway and hsa04360 (axon guidance pathway) (p < 0.001; FDR = 0.039, 0.041). Use of the ICSNPathway to analyze breast cancer GWAS data identified 16 candidate SNPs, 13 genes (including MBIP, RPS6KA1, and ITGB1), and 7 pathways that might contribute to the susceptibility of patients to breast cancer.

KW - Breast cancer

KW - Genome-wide association study

KW - Pathway-based analysis

UR - http://www.scopus.com/inward/record.url?scp=84922393415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922393415&partnerID=8YFLogxK

U2 - 10.1007/s13277-014-2027-5

DO - 10.1007/s13277-014-2027-5

M3 - Article

C2 - 24805830

AN - SCOPUS:84922393415

VL - 35

SP - 7699

EP - 7705

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 8

ER -